Although VPA treatment of epileptic patients showed a trend toward reductions in HCMV genome latent loads, patients would be expected to have fully functional immune systems.
← all excerpts
Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
1
—
—